These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20937404)

  • 1. Effect of mometasone furoate (MF)/formoterol fumarate (F) combination (MF/F) on late-phase responses in allergen-challenged Brown Norway rats.
    Chapman RW; Curran AK; House A; Richard J; Salisbury B; Hunter JC; Anthes JC; Phillips JE
    Pulm Pharmacol Ther; 2011 Feb; 24(1):67-73. PubMed ID: 20937404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effect of formoterol and mometasone in a mouse model of allergic lung inflammation.
    Wyss D; Bonneau O; Trifilieff A
    Br J Pharmacol; 2007 Sep; 152(1):83-90. PubMed ID: 17618304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mometasone furoate/formoterol in the treatment of persistent asthma.
    Berger WE
    Expert Rev Respir Med; 2011 Dec; 5(6):739-46. PubMed ID: 22082160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of inhaled roflumilast on the prevention and resolution of allergen-induced late phase airflow obstruction in Brown Norway rats.
    Chapman RW; House A; Jones H; Richard J; Celly C; Prelusky D; Ting P; Hunter JC; Lamca J; Phillips JE
    Eur J Pharmacol; 2007 Oct; 571(2-3):215-21. PubMed ID: 17610865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent anti-inflammatory effect of inhaled mometasone furoate/formoterol in subjects with asthma.
    Nolte H; Pavord I; Backer V; Spector S; Shekar T; Gates D; Nair P; Hargreave F
    Respir Med; 2013 May; 107(5):656-64. PubMed ID: 23490226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An assessment of change in asthma control among adolescents and adults with persistent asthma in mometasone furoate/formoterol fumarate clinical trials.
    Wyrwich KW; Ireland AM; Navaratnam P; Nolte H; Gates DF
    J Asthma; 2011 Feb; 48(1):48-56. PubMed ID: 21039190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory activity of inhaled mometasone furoate in allergic mice.
    Chapman RW; Sehring SJ; Garlisi CG; Falcone A; Kung TT; Stelts D; Minnicozzi M; Jones H; Umland S; Egan RW; Kreutner W
    Arzneimittelforschung; 1998 Apr; 48(4):384-91. PubMed ID: 9608881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of mometasone furoate / formoterol in the treatment of asthma.
    Westergaard CG; Porsbjerg C; Backer V
    Expert Opin Pharmacother; 2013 Feb; 14(3):339-46. PubMed ID: 23363416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal profile of forced expiratory lung function in allergen-challenged Brown-Norway rats.
    Celly CS; House A; Sehring SJ; Zhang XY; Jones H; Hey JA; Egan RW; Chapman RW
    Eur J Pharmacol; 2006 Jul; 540(1-3):147-54. PubMed ID: 16756974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appraisal of lens opacity with mometasone furoate/formoterol fumarate combination in patients with COPD or asthma.
    Maspero J; Cherrez I; Doherty DE; Tashkin DP; Kuna P; Kuo WL; Gates D; Nolte H; Chylack LT
    Respir Med; 2014 Sep; 108(9):1355-62. PubMed ID: 25044280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety of mometasone furoate/formoterol combination for treatment of patients with persistent asthma.
    Maspero JF; Nolte H; Chérrez-Ojeda I;
    J Asthma; 2010 Dec; 47(10):1106-15. PubMed ID: 20874458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of the late phase reduction in lung functions and correlations with microvascular leakage and lung edema in allergen-challenged Brown Norway rats.
    Mauser PJ; House A; Jones H; Correll C; Boyce C; Chapman RW
    Pulm Pharmacol Ther; 2013 Dec; 26(6):677-84. PubMed ID: 23523662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twenty-six-week efficacy and safety study of mometasone furoate/formoterol 200/10 microg combination treatment in patients with persistent asthma previously receiving medium-dose inhaled corticosteroids.
    Nathan RA; Nolte H; Pearlman DS;
    Allergy Asthma Proc; 2010; 31(4):269-79. PubMed ID: 20678306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mometasone furoate/formoterol reduces asthma deteriorations and improves lung function.
    Meltzer EO; Kuna P; Nolte H; Nayak AS; Laforce C;
    Eur Respir J; 2012 Feb; 39(2):279-89. PubMed ID: 21828036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-dependent effects of inhaled mometasone furoate on airway function and inflammation after allergen inhalation challenge.
    Inman MD; Watson RM; Rerecich T; Gauvreau GM; Lutsky BN; Stryszak P; O'Byrne PM
    Am J Respir Crit Care Med; 2001 Aug; 164(4):569-74. PubMed ID: 11520717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mometasone/formoterol inhalation aerosol: in asthma uncontrolled on medium- or high-dose inhaled corticosteroids.
    Frampton JE
    Drugs; 2012 Jun; 72(9):1229-41. PubMed ID: 22568730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the AQLQ12+ among adolescents and adults with persistent asthma.
    Wyrwich KW; Ireland AM; Navaratnam P; Nolte H; Gates DF
    Qual Life Res; 2011 Aug; 20(6):903-12. PubMed ID: 21184185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal mometasone furoate reduces late-phase inflammation after allergen challenge.
    Ciprandi G; Tosca MA; Passalacqua G; Canonica GW
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):433-8. PubMed ID: 11345288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of potential for pharmacokinetic interaction between mometasone furoate and formoterol fumarate after oral inhalation from a fixed-dose combination metered-dose inhaler device.
    Kosoglou T; Hubbell J; Johnson-Levonas AO; Yunan M; Kantesaria BS; Cutler DL
    Clin Pharmacol Drug Dev; 2014 May; 3(3):222-8. PubMed ID: 27128612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchodilation with mometasone furoate/formoterol fumarate administered by metered-dose inhaler with and without a spacer in children with persistent asthma.
    Berger WE; Bensch GW; Weinstein SF; Skoner DP; Prenner BM; Shekar T; Nolte H; Teper AA
    Pediatr Pulmonol; 2014 May; 49(5):441-50. PubMed ID: 24019197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.